(verbatim): Now that numerous important genes associated with tumor angiogenesis, invasion, and metastasis have been discovered, the grand challenge is to understand their function in intact animals. The second major challenge is to integrate and apply this knowledge to cancer prevention, detection and treatment. In the proposed BRPG, we will meet these challenges with a new, more precise, quantitative, integrative, and multi-disciplinary bioengineering approach. This new bioengineering approach builds on unique and innovative techniques such as 1) genetically engineered mice to visualize gene expression, 2) in vivo models to visualize molecular and cellular events, 3) computer-assisted in vivo microscopy to quantify gene expression and function continuously and non-invasively at high (1-10pm) resolution in intact animals, 4) mathematical modeling to integrate the resulting information. Using this powerful technology, we will investigate four critical aspects of tumor metastasis: angiogenesis, invasion, hematogenous metastasis and lymphangiogenesis lymphatic metastasis. In the first year we will achieve several significant milestones: i) critically test the longstanding but unproven hypothesis that angiogenesis litates metastasis by increasing cell shedding; ii) establish a quantitative link between cell traction force and invasion through the tissue matrix; iii) demonstrate that stress generated by proliferating cancer cells can collapse lymphatic vessels in tumors; iv) provide the quantitative relationship between nitric oxide (NO) and angiogenesis in vivo. In the second and third years we will build on these findings to provide deeper quantitative insight into expression and function of three genes (NO synthase, VEGF-A, VEGF-C) considered critical to these four aspects of metastasis. Years four and five will see integration of these data in a unified framework and identification of strategies for clinical translation. The proposed BRPG offers a new paradigm for integrative studies of the dynamics of gene expression and function in cancer. With this new paradigm available to our collaborating partners working at the forefront of genomics and proteonomics, this BRPG will facilitate translation of knowledge about the molecular biology of cancer into effective cancer prevention, detection, and treatment strategies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Resource-Related Research Projects (R24)
Project #
5R24CA085140-05
Application #
6798814
Study Section
Special Emphasis Panel (ZRG1-SSS-M (02))
Program Officer
Mohla, Suresh
Project Start
2000-07-20
Project End
2005-06-30
Budget Start
2004-07-01
Budget End
2005-06-30
Support Year
5
Fiscal Year
2004
Total Cost
$1,730,578
Indirect Cost
Name
Massachusetts General Hospital
Department
Type
DUNS #
073130411
City
Boston
State
MA
Country
United States
Zip Code
02199
Incio, Joao; Liu, Hao; Suboj, Priya et al. (2016) Obesity-Induced Inflammation and Desmoplasia Promote Pancreatic Cancer Progression and Resistance to Chemotherapy. Cancer Discov 6:852-69
Incio, Joao; Tam, Josh; Rahbari, Nuh N et al. (2016) PlGF/VEGFR-1 Signaling Promotes Macrophage Polarization and Accelerated Tumor Progression in Obesity. Clin Cancer Res 22:2993-3004
Fukumura, Dai; Incio, Joao; Shankaraiah, Ram C et al. (2016) Obesity and Cancer: An Angiogenic and Inflammatory Link. Microcirculation 23:191-206
Incio, Joao; Suboj, Priya; Chin, Shan M et al. (2015) Metformin Reduces Desmoplasia in Pancreatic Cancer by Reprogramming Stellate Cells and Tumor-Associated Macrophages. PLoS One 10:e0141392
Chauhan, Vikash P; Boucher, Yves; Ferrone, Cristina R et al. (2014) Compression of pancreatic tumor blood vessels by hyaluronan is caused by solid stress and not interstitial fluid pressure. Cancer Cell 26:14-5
Stylianopoulos, Triantafyllos; Martin, John D; Snuderl, Matija et al. (2013) Coevolution of solid stress and interstitial fluid pressure in tumors during progression: implications for vascular collapse. Cancer Res 73:3833-41
Jain, Rakesh K (2012) Delivery of molecular and cellular medicine to solid tumors. Adv Drug Deliv Rev 64:353-365
Chauhan, Vikash P; Stylianopoulos, Triantafyllos; Martin, John D et al. (2012) Normalization of tumour blood vessels improves the delivery of nanomedicines in a size-dependent manner. Nat Nanotechnol 7:383-8
Baish, James W; Stylianopoulos, Triantafyllos; Lanning, Ryan M et al. (2011) Scaling rules for diffusive drug delivery in tumor and normal tissues. Proc Natl Acad Sci U S A 108:1799-803
Goel, Shom; Duda, Dan G; Xu, Lei et al. (2011) Normalization of the vasculature for treatment of cancer and other diseases. Physiol Rev 91:1071-121

Showing the most recent 10 out of 46 publications